Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C2 | P08235 | 2/20 | 0.67 |
| ▸ | S1PR1 | P21453 | 13/20 | 0.40 |
| ▸ | PTPRC | P08575 | 1/20 | 0.38 |
| ▸ | PTGES | O14684 | 1/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.38 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29379459 | 0.94 | NR3C2 (0.77) | NR3C2S1PR1PTPRCPTGESS1PR3 | |
| SCHEMBL23275830 | 0.94 | NR3C2 (0.77) | NR3C2S1PR1PTPRCPTGESS1PR3 | |
| SCHEMBL29410842 | 0.94 | NR3C2 (0.77) | NR3C2S1PR1PTPRCPTGESS1PR3 | |
| SCHEMBL1380002 | 0.87 | NR3C2 (0.88) | NR3C2S1PR1PTPRCPTGESS1PR3 | |
| SCHEMBL23275819 | 0.85 | NR3C2 (0.59) | NR3C2S1PR1PTPRCS1PR3TRPV4 | |
| SCHEMBL12296563 | 0.85 | NR3C2 (0.75) | NR3C2S1PR1PTPRCPTGESS1PR3 | |
| SCHEMBL1378883 | 0.84 | NR3C2 (0.90) | NR3C2S1PR1PTPRCPTGESS1PR3 | |
| SCHEMBL23275799 | 0.84 | NR3C2 (0.58) | NR3C2S1PR1PTPRCPTGESS1PR3 | |
| SCHEMBL29410833 | 0.84 | NR3C2 (0.58) | NR3C2S1PR1PTPRCPTGESS1PR3 | |
| SCHEMBL23287494 | 0.83 | NR3C2 (0.56) | NR3C2S1PR1PTPRCPTGESS1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220211665-A1 | PYRROLE AMIDE COMPOUND AND USE THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2022-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220211665-A1 | PYRROLE AMIDE COMPOUND AND USE THEREOF | MC2R, NR3C2, AVPR2 | NR3C2 2/4885S1PR1 582/4885PTPRC 3118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.